benzhydrocodone

Trade name: Apadaz

Small moleculeapproved

Approved

Feb 23, 2018

Benzhydrocodone is an opioid prodrug of the morphinan class. Its chemical structure consists of hydrocodone coupled with benzoic acid. Benzhydrocodone itself is inactive and acts as a prodrug to hydrocodone upon cleavage of the benzoate portion of the molecule. — Wikipedia

Clinical trial activity

1 trials · 1 clinical orgs · 2 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Oct 31, 2014 (NCT02462850)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 3 Sponsor(trial)

  2. Feb 23, 2018

    Kvk Tech Inc — Earliest FDA Approval

  3. Feb 23, 2018

    Kvk Tech Inc — NDA Secondary Org

  4. Feb 23, 2018

    Kvk Tech Inc — NDA Organization

  5. Feb 23, 2018

    Zevra Therapeutics — NDA Secondary Org

Indications

Mechanism of action

Combination products

Approval history

  • approvedPriority reviewFeb 23, 2018

Chemistry & pharmacology

Loading structure…

SMILES

COc1ccc2c3c1O[C@H]1C(OC(=O)c4ccccc4)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341.Cl
Mol. weight
439.94 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02462850Phase 3Oct 31, 2014Charleston Laboratories, Inc
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Charleston Laboratories, IncFor profit1112014
1 organizations
Page 1 / 1

Marketing (3)

OrganizationOrg typeRelationshipDate
Kvk Tech IncFor profitNDA2Feb 23, 2018
Kvk Tech IncFor profitNDAFeb 23, 2018
Zevra TherapeuticsFor profitNDA2Feb 23, 2018